These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10155387)

  • 21. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 22. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.
    Brem H; Piantadosi S; Burger PC; Walker M; Selker R; Vick NA; Black K; Sisti M; Brem S; Mohr G
    Lancet; 1995 Apr; 345(8956):1008-12. PubMed ID: 7723496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gliadel wafers for treatment of brain tumors.
    Med Lett Drugs Ther; 1998 Sep; 40(1035):92. PubMed ID: 9760950
    [No Abstract]   [Full Text] [Related]  

  • 24. A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients.
    Pérez-Calvo J; Fernàndez O; Aristu JJ; Aramendia JM; Rifón J; Prosper F; Bendandi M; Rocha E; Martin-Algarra S
    Bone Marrow Transplant; 2004 Mar; 33(5):499-502. PubMed ID: 14716344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How safe are carmustine wafers?
    Grangeon L; Ferracci FX; Fetter D; Maltete D; Langlois O; Gilard V
    Rev Neurol (Paris); 2018 May; 174(5):346-351. PubMed ID: 29703443
    [No Abstract]   [Full Text] [Related]  

  • 26. More on the question of chemotherapy for CNS glioma.
    Ransohoff J
    Oncology (Williston Park); 1987 Dec; 1(10):19. PubMed ID: 3275335
    [No Abstract]   [Full Text] [Related]  

  • 27. New therapeutic agents in the treatment of recurrent high-grade gliomas.
    Brandes AA; Pasetto LM
    Forum (Genova); 2000; 10(2):121-31. PubMed ID: 10875974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient with resected anaplastic astrocytoma and an image suggestive of relapse.
    Maciá Escalante S; Rodríguez Lescure A; Segura Ibáñez JM; Sáez Castán J; Guillén Ponce C; Carrato Mena A
    Clin Transl Oncol; 2006 Dec; 8(12):912-4. PubMed ID: 17169765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial CT and MR imaging of carmustine wafers.
    Prager JM; Grenier Y; Cozzens JW; Chiowanich P; Gorey MT; Meyer JR
    AJNR Am J Neuroradiol; 2000 Jan; 21(1):119-23. PubMed ID: 10669235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on Bock et al. Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study. Acta Neurochir (2011) 153:533-539.
    Márquez-Rivas J; Rivero-Garvía M; Mayorga-Buiza MJ
    Acta Neurochir (Wien); 2012 Feb; 154(2):375-6; author reply 377. PubMed ID: 22146843
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing new methods for the treatment of malignant brain tumours: local delivery of anti-neoplastic agents using biodegradable polymers.
    Olivi A; DiMeco F; Bohan E; Brem H
    Forum (Genova); 2000; 10(2):152-65. PubMed ID: 10875976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carmustine and the lungs .
    Schmitz N; Diehl V
    Lancet; 1997 Jun; 349(9067):1712-3. PubMed ID: 9193378
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of glioblastoma multiforme with high doses of carmustine intracavitary, in an infant.
    Rivero-Garvía M; Márquez-Rivas J; Rueda-Torres AB; Pascual-Argente D; Ramírez G
    Childs Nerv Syst; 2012 May; 28(5):747-50. PubMed ID: 22205534
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study on drug delivery of the 3H-BCNU polylacties acid released agents on gliosarcoma].
    Zhang YP; Xu XN; Wang JH; Lu G; Liu P; Su TF; Liu HS; Qi JB; Gao B
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):568-9. PubMed ID: 12971860
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fatal pulmonary fibrosis induced by cytotoxic therapy].
    Somló P; Révész T
    Orv Hetil; 1984 May; 125(19):1143-5. PubMed ID: 6718003
    [No Abstract]   [Full Text] [Related]  

  • 37. Biodegradable polymers for drug delivery to the brain.
    Langer R
    ASAIO Trans; 1988; 34(4):945-6. PubMed ID: 2851308
    [No Abstract]   [Full Text] [Related]  

  • 38. [BCNU wafer].
    Ichikawa T
    Nihon Rinsho; 2016 Sep; 74 Suppl 7():650-653. PubMed ID: 30634828
    [No Abstract]   [Full Text] [Related]  

  • 39. Verapamil augments carmustine- and irradiation-induced senescence in glioma cells by reducing intracellular reactive oxygen species and calcium ion levels.
    Ham SW; Jeon HY; Kim H
    Tumour Biol; 2017 May; 39(5):1010428317692244. PubMed ID: 28459217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic therapies for malignant glioma: a guide for clinicians.
    Soffietti R; Bertero L; Pinessi L; Rudà R
    CNS Drugs; 2014 Dec; 28(12):1127-37. PubMed ID: 25403944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.